Neoadjuvant immune checkpoint inhibitor plus chemotherapy in rare tracheal tumors

[...]to deepen our understanding on the treatment of primary tracheal tumors, we report the application of neoadjuvant immunochemotherapy in two rare tracheal tumor cases. After induction treatment, the bronchoscopy showed no evident residual lesion, and no residual tumor was observed after treatment (Supplementary Figure S5E and F). [...]surgical resection was recommended due to the possibility of false-negative bronchoscopic biopsy, and lack of sufficient evidence in this clinical setting. [...]this preliminary report showed the potential clinical role of neoadjuvant immunochemotherapy for rare tracheal tumors.